ImmunoGen, Inc.
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Last updated:
Abstract:
Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to human folate receptor 1 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.
Status:
Application
Type:
Utility
Filling date:
21 Jul 2020
Issue date:
4 Feb 2021